Cognition Therapeutics Elucidates Genetic Mutation that Protects Against Alzheimer’s Disease
19 oct. 2020 08h00 HE
|
Cognition Therapeutics, Inc.
Pittsburgh, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular...
Cognition Therapeutics Receives $6.6M in NIA Grants for Two Studies of Elayta™ to Expand Understanding of Synaptoprotective Mechanism of Action
22 mai 2018 08h02 HE
|
Cognition Therapeutics, Inc.
PITTSBURGH, May 22, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of...
Cognition Therapeutics CEO Kenneth I. Moch Presenting at BioCentury Future Leaders Conference
03 avr. 2017 08h00 HE
|
Cognition Therapeutics, Inc.
Pittsburgh, April 03, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of...